Main Page
About US
Director Message
No. Decision and Establashment Date
vision & mission
Our objectives
Our achievements
Organization Chart
Administration
Executive Board
Administrative Board
Scientific Advisor Committee
Postgraduate Committee
Ethical Committee
Elite Student Program Committee
Administrative Unit
Secretary Unit
Employment Unit
Ordering and Purchasing Unit
IT Unit
Financial Unit
Public Relations and Marketing Unit
Transportation Unit
Researchers
Senior Staff
Research Leaders
Research Staff
Technical Staff Labs
Research Programs
About Research Programs
Biobanking & Biospecimen Research Program
Cancer Genomic Research Program
Functional & Developmental Genomics Research Progr
Genomic Screening Research Program
Neurogenetic Research Program
Pharmacogenomics Research Program
Tissue Culture & Regenerative Medicine Research
Research Service Units
About Research Service Units
Biobanking Unit
Bioimaging Unit
Bioinformatics Unit
Biomedical Engineering Unit
Diagnostic & Genomic Medicine Unit (DGMU)
Cytogenetic Service Unit
Molecular Service Unit
Flowcytometry Unit
Genetic Counselling Unit
High-Throughput Sequencing Unit
Histopathology Unit
Microarray (Affymetrix) Unit
Microarray (Agilent) Unit
Pharmacogenomics & Drug Discovery Unit
Preimplantation Genetic Diagnosis Unit
Proteomics and Metabolomics Unit
Quantitative Genotyping Unit
Teratogenecity & Toxicity Unit
Tissue Culture Unit
Education & Outreach Program
About Education & Outreach Program
Master of Science Program
About the Program
Master Students
Doctor of Philosophy Program
About the Program
Ph.D. Students
Training Program
About Program
Specialized Training Program in Clinical Cyto.
Public Awareness Program
Collaborations
About Collaborations
National Level Collaborations
International Level Collaborations
Quality Management Program
About Quality Management Program
QMP Outline
QMP Aims and Function
Publications
CEGMR Publication List
Submit Publication Permission Request
CEGMR Booklets
CEGMR Newsletter
CEGMR Workshops
Conferences and Seminars
CEGMR Training Programs
Conferences & Workshops
Conferences
Workshops
Seminars and Training Courses
Parteners
Academic Parteners
National
International
Commercial Parteners
National
International
Related Links
Government
Journals
Non-Governmental Organizations
International Organizations
Medical Dictionaries
Search Engines for Researchers
PhotoAlbum
Files
Contact Us
Center map
Site Map
Latest News
Our Events
CEGMR Research
Research
Application for Employment
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Center of Excellence In Genomic Medicine Research
Document Details
Document Type
:
Article In Journal
Document Title
:
Proliferative activity in Libyan breast cancer with comparison to European and central African patients
Proliferative activity in Libyan breast cancer with comparison to European and central African patients
Document Language
:
English
Abstract
:
BACKGROUND: We evaluated the relation of proliferative indices with clinicopathological features and prognosis in breast cancer (BC) of Libyan female patients. The data were compared with corresponding results in Finland and Nigeria. PATIENTS AND METHODS: Histological samples of breast cancer from 130 patients were retrospectively studied. Mitotic activity index (MAI) and standardized mitotic index (SMI) were estimated. RESULTS: There were statistically significant correlations between the proliferative indices and most clinicopathological features, with the strongest association observed for histological grade (P = 0.01 for SMI and P = 0.003 for MAI). The proliferative differences between Libyan, Nigerian, and Finnish population were prominent. The mean values of SMI and MAI in Libyan BC patients were 32.1 mitotic figures per square millimeter and 27.3 mitotic figures per 10 high-power fields, respectively. This is clearly lower than those in Nigeria but much higher than those in Finland. The differences between countries are seen in whole material and are also present in subgroups. The results indicated that mitotic activities can be reliable prognostic indicators in Libyan BCs, as they were among Finnish and Nigerian females. Univariate and multivariate analyses found at cut-offs of 19 and 44 mitosis/mm(2) of SMI were the most significant prognostic factors. CONCLUSIONS: Proliferative indices with careful estimation of the MAI and SMI could be applied as quantitative criteria for Libyan BC to separate the patients into good, moderate, and bad prognosis groups.
ISSN
:
2314-6133
Journal Name
:
BioMed research international
Volume
:
2013
Issue Number
:
1
Publishing Year
:
1434 AH
2013 AD
Article Type
:
Article
Added Date
:
Tuesday, April 12, 2016
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
Jamela Boder
Boder, Jamela
Researcher
Fathi Abdalla
Abdalla, Fathi
Investigator
Elfagieh Mohamed
Mohamed, Elfagieh
Researcher
Abdelbaset Buhmeida
Buhmeida, Abdelbaset
Researcher
Yrjö Collan
Collan, Yrjö
Researcher
Files
File Name
Type
Description
38528.pdf
pdf
Back To Researches Page